Cerebral Microbleeds in Critically Ill Patients with Respiratory Failure or Sepsis: A Scoping Review

Bing Yu Chen1, Johnny Dang2, Sung-Min Cho3

  • 1Cerebrovascular Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. chenb5@ccf.org.

Neurocritical Care
|March 20, 2024
PubMed
Abstract

Insights

Cerebral microbleeds (CMBs) are common in critically ill patients with ARDS or sepsis. These brain lesions often affect the corpus callosum and juxtacortical areas, but their long-term impact remains unclear.

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Radiology

Background:

  • Cerebral microbleeds (CMBs) are observed in critically ill patients experiencing respiratory failure, acute respiratory distress syndrome (ARDS), or sepsis.
  • Existing literature on critical illness-associated CMBs requires systematic summarization.

Purpose of the Study:

  • To systematically review and summarize the current literature on cerebral microbleeds in critically ill patients with respiratory failure, ARDS, or sepsis.

Main Methods:

  • A systematic search was conducted across five major databases (MEDLINE, Embase, CENTRAL, Scopus, Web of Science).
  • Studies included adult intensive care unit patients with respiratory failure, ARDS, or sepsis and evidence of CMBs on MRI.
  • Studies were excluded if CMBs had a clear alternative explanation for neurological injury.

Main Results:

  • The review included 48 studies involving 216 critically ill patients with CMBs.
  • Respiratory failure or ARDS was the primary condition in 91.2% of patients; sepsis was present in 2.3%, and both in 6.5%.
  • CMBs prevalence was 30% in patients with respiratory failure or ARDS, frequently impacting the corpus callosum (64.8%) and juxtacortical areas (41.7%).

Conclusions:

  • Cerebral microbleeds are frequently identified in critically ill patients with respiratory failure, ARDS, or sepsis.
  • The predilection for corpus callosum and juxtacortical areas may be characteristic of critical illness-associated CMBs.
  • Functional and cognitive outcomes associated with these microbleeds are largely undetermined.